Three new medical centers adopt daxor's blood volume diagnostic signaling growing clinical acceptance

Daxor's innovative ezbva lab service drives accessibility and operational efficiency oak ridge, tn, may 06, 2025 (globe newswire) -- daxor corporation (nasdaq: dxr), the global leader in blood volume measurement technology, today announces significant expansion of its blood volume analysis (bva) capabilities in three new hospitals. this growth is accelerated by the widespread adoption of daxor's ezbva lab service – a cutting-edge, clia-certified facility delivering precise, on-demand blood volume analysis results within 24 hours.
DXR Ratings Summary
DXR Quant Ranking